Has Victoria Forte received payments from drug or device companies?

Yes. Drug and device makers reported $28,593 in general payments to Victoria Forte across 187 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Victoria Forte did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Victoria Forte come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Victoria Forte

Hematology & Oncology · Brooklyn, NYNPI 1144548736

Payments from drug & device makers

$28,593in general payments, 2019–2025

Across 187 payments — averaging $152.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$17K
Gilead$5K
Merck$2K
Blueprint Medicines Corporation$827
E.r. Squibb & Sons, L.L.C.$681
Pfizer$317
plus $3K from 39 others

What the payments were for

Consulting fees$3,28028%
Travel & lodging$3,96034%
Food & beverage$4,45238%
Education$1221%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	1	$16,780
Gilead	28	$4,975
Merck	13	$2,345
Blueprint Medicines Corporation	1	$827
E.r. Squibb & Sons, L.L.C.	39	$681
Pfizer	15	$317
Daiichi Sankyo Inc.	7	$261
GSK	6	$216
Novartis	11	$213
Focal Therapeutics, Inc.	1	$203
AstraZeneca	5	$198
Johnson & Johnson(2 entities)	7	$169
Bristol Myers Squibb	5	$139
Geron Corporation	1	$120
Adaptive Biotechnologies Corporation	2	$119
Regeneron Healthcare Solutions, Inc.	3	$93
Lilly USA, LLC	3	$69
Ipsen Biopharmaceuticals, Inc	1	$64
EMD Serono, Inc.	3	$62
Array Biopharma Inc	3	$58
Foundation Medicine, Inc.	1	$49
Bayer	3	$47
Sumitomo Pharma America, Inc.	2	$47
Janssen Research & Development, LLC	1	$40
Exelixis Inc.	2	$36
CSL Behring	2	$36
Octapharma USA, Inc.	2	$35
Genmab U.S., Inc.	1	$32
Beigene USA, Inc.	1	$31
AbbVie	2	$29
Seagen Inc.	1	$25
Servier Pharmaceuticals LLC	1	$25
Stemline Therapeutics Inc.	1	$24
G1 Therapeutics, Inc.	1	$24
Dova Pharmaceuticals	1	$24
Astellas Pharma US Inc	1	$23
Tactile Systems Technology Inc	1	$22
Amgen	1	$22
Genentech USA, Inc.	1	$20
Puma Biotechnology, Inc.	1	$19
Incyte Corporation	1	$17
Jazz Pharmaceuticals Inc.	1	$17
Myriad Genetic Laboratories, Inc.	1	$17
Taiho Oncology, Inc.	1	$13
Boston Scientific	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Trodelvy$4,306
BioZorb$203
Localizer$203
CALQUENCE$125
Enhertu$125
RYTELO$120
ZEJULA$116

How this compares

$28,593 in reported general payments places this provider in the 65th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Anastrozole	11	$104

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Brooklyn

Vicky MakkerNew York$27.1M
Alison MoskowitzNew York$22.7M
Ajai ChariNew York$22.4M
Yelena JanjigianNew York$16.9M
Alexander LesokhinNew York$11.9M
John MascarenhasNew York$11.8M
Maria PalombaNew York$11.6M
Richard ZunigaBabylon$10.9M
Scott TagawaNew York$10.3M
Mohammad Abdul HayNew York$9.9M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →